Tel:   08-7520100     E-post:

Fredrik Källmark om behandling av torra ögon i International Journal of Ophthalmic Practice

A paradigm shift have occurred in DED management from simply lubricating and hydrating the ocular surface with artificial tears to strategies that stimulate natural production of tear constituents, maintain ocular surface epithelial health and barrier function, and inhibit the inflammatory factors that adversely impact the ability of the ocular surface and glandular epithelia to produce tears. Preliminary experience with this new therapeutic approach suggests that quality of life can be improved for many patients with dry eye, and that initiating these strategies early in the course of the disease may prevent potentially blinding complications of DED.

Läs hela artikeln som PDF

Share this post